BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/6/2019 10:17:05 PM | Browse: 390 | Download: 467
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial
|
Manuscript Source |
Invited Manuscript |
All Author List |
Youn I Choi, Jun Won Chung, Dong Kyun Park, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim and Ja Young Seo |
Funding Agency and Grant Number |
|
Corresponding Author |
Jun Won Chung, MD, PhD, Associate Professor, Doctor, Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center, 21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@hanmail.net |
Key Words |
Helicobacter pylori; Eradication; Tailored; Empirical; Quadruple; |
Core Tip |
Few studies have compared the efficacy and safety profile of a tailored eradication (TR) strategy based on the presence of a 23S ribosomal RNA point mutation with those of empirical bismuth-based quadruple therapy (EBQT) as first-line eradication for Helicobacter pylori infection in Korean patients.
In this prospective, open-label, comparative study results, the first-line eradication rate of H. pylori did not statistically differ between the strategy of TR and EBQT. However, the rate of eradication-related side effects was significantly lower in TR than EBQT strategy.
TR H. pylori eradication using DPO-PCR may be equally efficacious, with less treatment-related complications, compared to EBQT in Korea, where clarithromycin resistance is high. |
Citation |
Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751 |
|
Received |
|
2019-09-27 09:55 |
|
Peer-Review Started |
|
2019-09-27 09:55 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-11-10 05:44 |
|
Revised |
|
2019-11-30 07:27 |
|
Second Decision |
|
2019-12-06 07:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-12-06 22:17 |
|
Articles in Press |
|
2019-12-06 22:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-12-10 01:44 |
|
Typeset the Manuscript |
|
2019-12-13 06:24 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345